杭氧股份(002430):半年报点评:气体销售业务回暖,积极开拓海外市场

Investment Rating - The investment rating for the company is "Buy" and is maintained [9] Core Views - The company reported a revenue of 7.327 billion yuan for the first half of 2025, representing a year-on-year increase of 8.92%, and a net profit attributable to shareholders of 479 million yuan, up 9.61% year-on-year [2][6] - The gas sales business is recovering, with a 14.12% year-on-year increase in gas sales revenue, while the petrochemical product revenue grew by 50.28% [12] - The company is actively expanding into overseas markets, achieving a 78.89% year-on-year growth in overseas sales [12] - The gross profit margin for Q2 2025 was 20.05%, a decrease of 1.44 percentage points year-on-year, but is expected to recover in the second half of 2025 [12] - Operating cash flow improved significantly, reaching 1.215 billion yuan in H1 2025, an increase of 97.84% year-on-year [12] Summary by Sections Financial Performance - In H1 2025, the company achieved a total revenue of 73.27 billion yuan, with Q2 revenue at 37.63 billion yuan, both showing positive year-on-year growth [2][6] - The net profit for H1 2025 was 4.79 billion yuan, with Q2 net profit at 2.53 billion yuan, indicating consistent profitability [2][6] Business Segments - The gas sales business showed a year-on-year increase of 14.12%, while the engineering contracting business saw a decline of 44.05% [12] - The company maintained a leading position in the domestic market for petrochemical equipment, with a record contract amount of 8.41 billion yuan in H1 2025 [12] Market Expansion - The company has made significant strides in overseas markets, with a notable increase in sales and the establishment of subsidiaries in Southeast Asia [12] - The gross margin for overseas sales improved by 5.34 percentage points, benefiting from competitive pricing and tax rebate policies [12] Future Outlook - The company anticipates a steady increase in gas sales volume and the successful development of new business areas such as standard gases and medical gases in H2 2025 [12] - Projected net profits for 2025-2027 are estimated at 1.055 billion, 1.230 billion, and 1.453 billion yuan, respectively, with corresponding PE ratios of 23, 20, and 17 times [12]